Migraine is a debilitating neurological disease that is three times more common in women than men, placing significant burden on women, their families, and society as a whole. In October 2017, SWHR hosted an interdisciplinary roundtable discussion on sex and gender differences in migraine, followed by a public panel discussion. The closed roundtable consisted of 13 experts, including basic scientists, clinicians, behavioral scientists, and patient advocates, discussing the current state of the science regarding the role of sex and gender differences in migraine and steps needed to address gaps in knowledge.
Roundtable participants authored an expert review, Sex and Gender Differences in Migraine — Evaluating Knowledge Gaps, published in the Journal of Women’s Health in August 2018. This roundtable and public panel laid the foundation for SWHR’s Migraine Network and its resource the Migraine Patient Toolkit.
Jan Lewis Brandes, MD, Nachville Neuroscience Group
Dawn C. Buse, PhD, Albert Einstein College of Medicine
Anne Calhoun, MD, Carolina Headache Institute
Katharina Eikermann-Haerter, MD, Harvard Medical School
Katie M. Golden, Golden Graine
Rashmi Halker Singh, MD, Mayo Clinic
Joanna Kempner, PhD, Rutgers University
Nasim Maleki, PhD, Harvard Medical School
Maureen Moriarty, DNP, Georgetown University
Jelena Pavlovic, MD, PhD, Albert Einstein College of Medicine
Robert E. Shapiro, MD, PhD, University of Vermont
Amaal Starling, MD, Mayo Clinic
William B. Young, MD, Thomas Jefferson University
SWHR’s Migraine Program is supported by educational sponsorships from Amgen, Eli Lilly & Co., Novartis, and Teva. SWHR maintains editorial control and independence over educational content.